New tracer Flyrcado (flurpiridaz F 18)—a PET myocardial perfusion imaging (MPI) agent developed for use in patients with known or suspected CAD—gains Medicare and commercial coverage.
Oncologists have access to advanced imaging technologies for cancer patient care with the new Celesteion PUREViSION edition PET/CT system from Toshiba Medical. The newest edition of Celesteion allows for ease and efficiency in PET/CT, CT simulation, and diagnostic CT exams, to help diagnose and treat oncology patients.
New tracer Flyrcado (flurpiridaz F 18)—a PET myocardial perfusion imaging (MPI) agent developed for use in patients with known or suspected CAD—gains Medicare and commercial coverage.